Subfoveal choroidal thickness changes after intravitreal bevacizumab injection for neovascular age-related macular degeneration and diabetic macular edema.

MLA

Ünlü, Cihan, et al. “Subfoveal Choroidal Thickness Changes after Intravitreal Bevacizumab Injection for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema.” International Ophthalmology, vol. 37, no. 1, Feb. 2017, pp. 147–58. EBSCOhost, https://doi.org/10.1007/s10792-016-0242-3.

APA

Ünlü, C., Erdogan, G., Gunay, B., Kardes, E., Akcay, B., & Ergin, A. (2017). Subfoveal choroidal thickness changes after intravitreal bevacizumab injection for neovascular age-related macular degeneration and diabetic macular edema. International Ophthalmology, 37(1), 147–158. https://doi.org/10.1007/s10792-016-0242-3

Chicago

Ünlü, Cihan, Gurkan Erdogan, Betul Gunay, Esra Kardes, Betul Akcay, and Ahmet Ergin. 2017. “Subfoveal Choroidal Thickness Changes after Intravitreal Bevacizumab Injection for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema.” International Ophthalmology 37 (1): 147–58. doi:10.1007/s10792-016-0242-3.